“…( S )‐Naproxen (Nap, 6‐methoxy‐ α ‐methyl‐2‐naphthaleneacetic acid), having a carboxylic acid group, high molar absorptivity ( ε >100,000) and commercial availability as the pure ( S )‐enantiomer, is suitable for the preparation of CDRs, which can be used for the indirect chiral chromatographic separation of amino group‐containing analytes. CDRs prepared by the reaction of ( S )‐Nap with (a) N ‐hydroxysuccinimide (H‐Suc) providing N ‐succinimidyl‐( S )‐2‐(6‐methoxynaphth‐2‐yl) propionate (SINP, CDR1; Bhushan and Tanwar, ), (b) 1 H ‐benzotriazole (H‐Btz) providing ( S )‐1‐[1 H ‐benzo(d)(1,2,3)triazol‐1‐yl]‐2‐(6‐methoxynaphthalen‐2‐yl)propan‐1‐one (Nap‐Btz, CDR2; Bhushan and Dubey, ; Bhushan and Nagar, ), (c) N ‐hydroxyphthalimide (H‐Phth) providing N ‐phthalimidyl‐( S )‐2‐(6‐methoxynaphth‐2‐yl) propionate (Nap‐Phth, CDR3; Bhushan and Nagar, ) and (d) hydrazine hydrate (Bhushan and Lal, ) have been used for the indirect enantioresolution of penicillamine, cysteine, homocysteine, selenomethionine and 18 proteinogenic amino acids, and certain carbonyl compounds. These CDRs were shown to require only mild derivatization conditions and shorter reaction time, and were sensitive to amino groups.…”